Vivos Therapeutics VVOS
NASDAQ VVOS
$0.10 +0.00 (+2.24%)
At close: Nov 9, 2026 · 4:00 PM EST

Vivos Therapeutics (VVOS) Asset Writedowns and Impairment (2023)

Updated

Analysis

Vivos Therapeutics (VVOS) Asset Writedowns and Impairment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Vivos Therapeutics 1.68 Mn -7.36 Mn 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 151,000.00
API Access

Vivos Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VVOS&period=max&api_key=YOUR_API_KEY